Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.4 HKD | -5.15% | +29.38% | -10.78% |
06-04 | Akeso Expands Territory of License Agreement for Lung Cancer Drug | MT |
06-03 | Summit Therapeutics Inc. Expands License Territories for Ivonescimab | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
4.84B | - | |||||
125B | ||||||
109B | ||||||
24.74B | - | |||||
22.67B | - | |||||
18.14B |
- Stock Market
- Equities
- 9926 Stock
- Charts Akeso, Inc.
- Sector Chart